Figure 2.
Hepatocellular carcinoma risk stratification of untreated HBeAg-negative chronic hepatitis B patients by HBV DNA, HBsAg and HBcrAg. HBcrAg, hepatitis B core-related antigen; HBeAg, hepatitis B e antigen; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; ALT, alanine aminotransferase; HCC, hepatocellular carcinoma.